HOME >> BIOLOGY >> NEWS
Emory University Fragile X Group Receives NIH Program Grant

Researchers from seven interrelated and collaborative projects all focusing on fragile X syndrome, the most frequent cause of inherited mental retardation in humans, have received a program project grant from the National Institutes of Health (NIH) totaling approximately $3.7 million. The research group, assembled by Stephen Warren, Ph.D., W. T. Timmie Professor of Biochemistry in the Emory University School of Medicine, and a Howard Hughes Medical Institute Investigator (see sidebar), will try to further clarify the molecular basis of fragile X syndrome and expand the scope of contemporary fragile X syndrome research.

In recent years there has been a spectacular increase in the understanding of the fragile X syndrome, with many of the major discoveries originating in Dr. Warren's laboratory. Dr. Warren and his colleagues discovered in 1991 the gene responsible for fragile X syndrome, FMR1, and were among the first to develop genetic tests to diagnose the disease. In 1993 they discovered FMRP, the protein expressed by the normal FMR1 gene and learned that fragile X syndrome occurs when the FMR1 gene does not produce the FMRP protein. That protein suppression is responsible for the symptoms of the disease, namely mental retardation, attention deficit disorder and connective tissue disorders.

The scientists also learned that most affected patients share a common genetic mutation called triplet repeats. All genes are made of combinations of four chemicals, abbreviated A, C, G and T. Within the FMR1 gene, the triple combination of CGG, CGG, etc., is usually repeated only 30 times in unaffected persons, but between 230 to 1,000 times in those affected by fragile X syndrome.

With this knowledge, genetic counselors have been able to help carriers of FMR1 predict the probability of giving birth to a child affected by the syndrome, and pediatricians a
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404/727-3990
Emory University Health Sciences Center
26-Jan-1998


Page: 1 2 3

Related biology news :

1. Emory researchers map structure of anti-cancer molecule
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases
4. Emory researchers develop model to track the evolution of emerging infectious diseases
5. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
6. Emory scientists track down immune sentinel cells with gene gun
7. Emory researchers discover novel mechanism of how anthrax impairs immunity
8. Emory scientists find anti-tumor compounds in magnolia cones
9. Emorys CancerQuest wins top Web award from Scientific American
10. Emory University researchers uncover novel self-assembly of Alzheimers amyloid fibrils
11. Emory Vaccine Research Center study identifies specific gene required for long-term immunity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Pharmafusion LLC ... a featured presenter at the upcoming CBI Gross-to-Net (GTN) Summit in Philadelphia on ... Friday, November 16, where conference attendees will have the opportunity to “test drive” ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... virtual events and webinars, will be hosting its 9th Annual Clinical Diagnostics ... technologies and treatments available, and updates in regulatory processes to ensure patient safety ...
(Date:11/9/2018)... ... November 08, 2018 , ... Boekel ... Heating blocks, also known as dry bath incubators are used in laboratories worldwide ... , For the new heating blocks, Boekel Scientific used the same interface ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... NASHVILLE, Tenn. (PRWEB) , ... November 05, 2018 ... ... Accredited radiology and telemedicine company backed by Siemens Healthineers and several healthcare VC ... blockchain based radiology solution and making a history by purchasing tokens and obtaining ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has ... Activator Like (TAL) effector code technology for applications in advancing research in epigenetic ... in plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting ...
(Date:11/3/2018)... ... , ... Triangle Insights Group, a premier life sciences consulting firm, announced today ... in the United States, appearing on this year’s Inc. 5000 list. Since its ... growth over the previous three years. , Separately, Triangle Insights was also ranked ...
(Date:10/31/2018)... ... October 30, 2018 , ... ... trial at the Campbell Clinic in Memphis, Tennessee. This study enrolled 125 ... standard of care for managing pain after total knee replacement surgery (TKA). , ...
Breaking Biology Technology:
Cached News: